Other
Pulmonary Disease
0
Pipeline Programs↗
3
Active Trials↗
0
Companies Involved↗
Pulmonary Disease is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
8
clinical trials
Recruiting3 · 38%
Unknown status2 · 25%
Completed2 · 25%
Terminated1 · 13%
Clinical Trials
Trial Activity
8 trials
Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
Recruiting·—·Phase 1·NCT04624490·260 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)